Skip to content

Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block

Comparison Between Bupivacaine 0.5% Versus Bupivacaine 0.25% Plus Lidocaine 1% in Ultrasound-guided Infraclavicular Block: a Prospective Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05834023
Enrollment
40
Registered
2023-04-27
Start date
2023-05-02
Completion date
2024-01-05
Last updated
2024-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Pain, Acute, Postoperative Pain

Keywords

Bupivacaine, Lidocaine, Nerve Block, Infraclavicular Block, Upper Extremity Surgery

Brief summary

In this study, the investigators will compare two different anesthetic solutions in the infraclavicular block in patients having forearm, wrist, and hand surgery. The solutions will be bupivacaine 0.5% versus bupivacaine 0.25% plus lidocaine 1%, both associated with epinephrine 5 mcg/ml and dexamethasone 4 mg. The main objective of this investigation is to demonstrate that using higher concentrations of bupivacaine alone results in a significant block duration increase compared with the mixture of bupivacaine and lidocaine.

Interventions

DRUGBupivacaine-Lidocaine

Infraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.25% + Lidocaine 1% + dexamethasone 4 mg + epinephrine 5 mcg/ml

DRUGBupivacaine

Infraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.5% + dexamethasone 4 mg + epinephrine 5 mcg/ml

Sponsors

Hospital de San Carlos Dr. Benicio Arzola Medina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

A research assistant will prepare the solutions before the procedure, utilizing bupivacaine alone or mixing bupivacaine and lidocaine as appropriate. The operator, patient, and investigator assessing the block will be blinded to group allocation.

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 80 years * American Society of Anesthesiologists classification 1-3 * Surgery of the forearm, wrist, and hand * Weight ≥ 80 kilograms

Exclusion criteria

* Adults who are unable to give their consent * Infection in the injection site (infraclavicular region) * Pre-existing neuropathy (assessed by history and physical examination) * Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work, i.e., platelets ≤ 100, International Normalized Ratio ≥ 1.4) * Renal failure (assessed by history and physical examination and if deemed clinically necessary, by blood work, i.e., creatinine ≥ 1.2) * Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work, i.e., transaminases ≥ 100) * Allergy to local anesthetics (LAs) * Pregnancy or breastfeeding * Prior surgery in the infraclavicular region * Chronic pain syndromes requiring opioid intake at home

Design outcomes

Primary

MeasureTime frameDescription
Motor block duration0 - 48 hours after blockThe time interval in minutes between the end of the local anesthetic injection and the return of hand mobility.

Secondary

MeasureTime frameDescription
Sensory block duration0 - 48 hours after blockThe time interval in minutes between the end of the local anesthetic injection and the return of hand sensation.
Analgesic block duration0 - 48 hours after blockThe time interval in minutes between the end of the local anesthetic injection and the first sensation of pain in the surgical area.
Sensory and motor block score0 - 60 minutes after blockThe sensorimotor block will be assessed every 5 minutes until 60 minutes after the end of local anesthetic injection using a 16-point composite score evaluating sensory and motor block of musculocutaneous, median, radial, and ulnar nerves. Sensation will be assessed with a pinprick test in each nerve territory with a 0 to 2-point scale. 0= no block, patients can feel a pin prick; 1= analgesic block, the patient can feel touch but not pinprick; 2= anesthetic block, the patient cannot feel pinprick or touch. The motor function will be assessed for each nerve with a 0 to 2 points scale where 0= no motor block; 1= paresis; 2= paralysis.
Block onset time0 - 60 minutes after blockThe time interval in minutes between the end of the local anesthetic injection and a minimal sensorimotor composite score of 14 out of 16 points. The sensorimotor score is described in Outcome 4.
Incidence of successful block0 - 60 minutes after blockPatients with a minimal sensorimotor score of 14 out of 16 points, with at least 7 points in the sensitive score. The sensorimotor score is described in Outcome 4.
Incidence of anesthetic block60 to 120 minutes after the ending time of local anesthetic injectionAbility to proceed with the surgery without general anesthesia, rescue blocks, or local anesthesia infiltration by the surgeon.
Procedural painImmediately after nerve blockPain related to the nerve block according to the Numeric Rating Scale for Pain. This scale is graduated from 0 to 10 points. A 0-point score represents the absence of pain, and a 10-point score means the worst imaginable pain.
Image time2 hours before surgeryThe time interval in seconds between the probe placement and the acquisition of the final ultrasonographic image.
Needle time2 hours before surgeryThe time interval in seconds between the skin infiltration and the end of local anesthetic injection
Block performance time2 hours before surgerySum of image and needle time
Incidence of failed block0 - 60 minutes after blockPatients with a sensorimotor score of 13 points or less. The sensorimotor score is described in Outcome 4.
Diaphragmatic functionFrom arrival to the pre-anesthesia unit to the end of surgeryDiaphragmatic excursion in millimeters evaluated by ultrasound in three different times: pre-block, 60 minutes after block, and at the end of the surgery
Rate of diaphragmatic paresisFrom 60 minutes after block to the end of the surgeryPatients with decreased diaphragmatic excursion by 25% to 75% compared with the basal function 60 minutes after the block or at the end of the surgery.
Rate of diaphragmatic paralysisFrom 60 minutes after block to the end of the surgeryPatients with decreased diaphragmatic excursion greater than 75% compared with the basal function, absence of diaphragmatic movement, or paradoxical movement 60 minutes after the block or at the end of the surgery.
Incidence of rebound pain24 hours after the block wears offSevere pain (NRS ≥ 7) in the surgical area within 24 hours after the block wears off.
Incidence of nerve block side effectsFrom skin anesthesia to 60 minutes after the nerve blockThe presence of Horner syndrome, paresthesia, vascular puncture, hematoma, or local anesthetic systemic toxicity after the nerve block.
Postoperative complications7 days after surgeryPresence of persistent paresthesia, numbness, or motor deficit in the postoperative period.
Duration of surgery3 hours after skin incisionTime in minutes between skin incision and closure.
Pain score in the post-anesthesia care unit (PACU)3 hours after the end of the surgeryHighest pain reported by the patient in the PACU according to the Numeric Rating Scale for Pain. This scale is graduated from 0 to 10 points. A 0-point score represents the absence of pain, and a 10-point score means the worst imaginable pain.
Length of PACU stay3 hours after the end of the surgeryThe time interval in minutes between PACU arrival to readiness to discharge
Number of patients requiring general anesthesia60 to 120 minutes after the ending time of local anesthetic injectionPatients who need general anesthesia to proceed with the surgery

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026